Processing, please wait...

Debraj SHOME 医师

颈面部整形外科医师
印度

Dr. Debraj Shome is an internationally trained Facial Plastic Surgeon, currently based in Mumbai, India. Dr. Shome is the inventor of the QR 678, the iconic hair growth product which has an US patent and an Indian patent and FDA approval in multiple countries. Dr. Shome is the obnly surgeon from Asia to be American Board certified in Facial Cosmetic Surgery. Dr. Debraj Shome has also co-founded The Esthetic Clinics, a chain of top class aesthetic centers located in multiple cities in India. 

Dr. Shome is a Consultant Facial Plastic & Cosmetic Surgeon at many top hospitals in Mumbai. Dr. Shome is also a Visiting Faculty to the Department of Head and Neck Surgery at the M D Anderson Cancer Center, Houston, USA. He was the co-founder of The Esthetic Clinics at Apollo health City, Hyderabad. Dr. Shome is an internationally renowned and noted Facial Plastic Surgeon who specializes in facial cosmetic & reconstructive surgery, facial & ocular cancers and orbital surgery and is one of very few Indian surgeons listed by Wikipedia, the world’s largest online encyclopedia (http://en.wikipedia.org/wiki/Debraj_Shome).

Dr. Shome obtained the degrees of F.R.C.S. (Fellow of Royal College of Physicians and Surgeons of Glasgow) in 2003 and also his Diplomate of National Board (D.N.B.) in 2004. He specialized in Ophthalmic Plastic surgery and Orbital surgery in a rigorous fellowship from L.V. Prasad Eye Institute, Hyderabad, India. Dr. Shome subsequently completed an esteemed clinical fellowship in Cosmetic Facial Plastic surgery from one of the world's top centers at the University of Utah, Salt Lake City, USA. Dr. Shome completed another Fellowship in Maxillofacial Surgery under the aegis of the AOCMF in May 2015 and a Fellowship in Head & Neck Surgery from the Department of Head & Neck Surgery at the M D Anderson Cancer Center in August 2007. Dr. Shome is thus one of very few plastic surgeons with dedicated training in four different sub-specialties of facial plastic surgery.

For his medical and entrepreneurial activities, Dr. Shome was awarded in 2017 as "Indian of The Year" by the Indian Leadership Conclave.

更多详情
add item 加入 Debraj SHOME

Debraj SHOME's 的发布 (32)

Orbital tuberculosis: a review of the literature.

2008

To provide an up-to-date review of the clinical presentations, investigations, and management of orbital tuberculosis (OTB). 更多详情

Orbit (Amsterdam, Netherlands)

Community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA)--a rare cause of fulminant orbital cellulitis.

2008

We report a 55-year-old female patient who developed a severe right-sided orbital cellulitis. Past history was significant for a boil on the right upper eyelid 2 days prior. Visual acuity at presentation was perception of light with inaccurate projection. Orbital computed tomography (CT) scan and routine blood investigations, including blood culture, urine examination, and urine culture, were performed. CT scan showed a superonasal orbital mass suggestive of an abscess. Abscess drainage followed by pus culture, sensitivity, and pulsed-field gel electrophoresis revealed community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) resistant to all antibiotics except vancomycin, cotrimoxazole, and amikacin. The condition completely resolved post antibiotic and steroid therapy. At 3 months follow-up, the vision in the right eye was 6/9. We report this case to highlight CAMRSA as a rare but virulent cause of orbital cellulitis; empiric antibiotic therapy should include coverage for CAMRSA until susceptibilities come back. 更多详情

Orbit (Amsterdam, Netherlands)

Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial.

May, 2014

The purpose of the study is to compare the intra-vitreal concentrations of carboplatin, post peri-ocular injections of commercially available carboplatin (CAC) and a novel carboplatin loaded polymethylmethacrylate nanoparticulate carboplatin (NPC), in either eye, as a model system for treatment of advanced intra-ocular retinoblastoma (RB). 更多详情

Indian journal of ophthalmology
装载更多